Watchlist Price Alert

Meridian Bioscience Inc. (VIVO)

NASDAQ: VIVO · Real-Time Price · USD

33.97

0.00 (0.00%)

At close: Jan 30, 2023, 10:00 PM

Meridian Bioscience Cash Flow Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Net Income	42.46M	71.41M	46.19M	24.38M	23.85M	21.56M	32.23M
Depreciation & Amortization	16.51M	15.29M	13.57M	9.96M	7.92M	8.12M	6.63M
Stock-Based Compensation	6.9M	4.16M	3.8M	3.25M	3.4M	3.38M	2.91M
Other Working Capital	-988K	-4.04M	1.28M	-251K	-201K	-54K	-5.88M
Other Non-Cash Items	7.75M	-1.89M	-4.92M	90K	1.57M	6.88M	1.57M
Deferred Income Tax	-1.1M	-3.83M	760K	-817K	-300K	1.47M	-233K
Change in Working Capital	9.84M	-18.26M	-11.42M	-1.04M	-1.67M	-54K	-5.88M
Operating Cash Flow	82.36M	66.86M	47.98M	35.83M	34.78M	41.35M	37.22M
Capital Expenditures	-8.62M	-18.31M	-3.3M	-3.8M	-4.2M	-4.47M	-4M
Cash Acquisitions	-3.75M	-23.59M	-51.3M	-45.32M	n/a	n/a	-62.09M
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	-600K
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	1.25M	1.5M	n/a	669K	n/a	n/a	n/a
Investing Cash Flow	-11.12M	-40.4M	-54.6M	-48.45M	-4.2M	-4.47M	-66.69M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	-10.61M	-21.17M	-24.27M	-33.65M
Other Financial Acitivies	-34.3M	-31.07M	-3.56M	25.87M	-6.42M	-3.45M	60.85M
Financial Cash Flow	-34.3M	-31.07M	-3.56M	15.26M	-27.59M	-27.71M	27.2M
Net Cash Flow	31.68M	-3.74M	-8.88M	1.63M	2.69M	9.85M	-2.75M
Free Cash Flow	73.75M	48.55M	44.68M	32.03M	30.58M	36.89M	33.22M